CDC to Review COVID Vaccine Injuries
CDC vaccine advisors are set to review cases of COVID-19 vaccine injuries and evaluate ongoing needs of people with long COVID. The advisory process is part of broader efforts to address public concerns and inform future vaccination strategies with increased transparency.
The upcoming review by the CDC's vaccine advisory panel, the Advisory Committee on Immunization Practices (ACIP), is scheduled for March 18-19, 2026. This meeting was rescheduled from its original late February dates. On the agenda are discussions and potential votes regarding COVID-19 vaccine injuries and long COVID. This meeting follows a significant overhaul of the ACIP. Last year, Health and Human Services Secretary Robert F. Kennedy Jr. replaced all 17 of the committee's members. The reconstituted panel has already made notable changes to U.S. vaccination policy, including shifting the recommendation for COVID-19 shots to a matter of "individual-based decision-making" in consultation with a doctor. For individuals who believe they have been injured by a COVID-19 vaccine, the available recourse is the Countermeasures Injury Compensation Program (CICP), not the more widely known National Vaccine Injury Compensation Program (VICP). The CICP was established by the PREP Act in 2005 to provide compensation for serious injuries or deaths from countermeasures used during a public health emergency, and it shields vaccine manufacturers from lawsuits. The CICP has a much shorter claim filing deadline of one year from the injury, compared to the VICP's three-year window. Since the pandemic began, the CICP has received a massive influx of claims, receiving about 27 times more claims in response to COVID-19 than in its first decade of operation. As of June 2024, approximately $400,000 had been paid for injuries related to COVID-19 countermeasures, such as myocarditis. The committee will also evaluate the ongoing needs of individuals with long COVID, a condition that can affect multiple organ systems with a wide range of symptoms. A recent meta-analysis of 64 studies found that fatigue is the most common symptom, often appearing alongside joint pain, cognitive issues, or respiratory problems. Respiratory symptoms were the most common cluster, impacting an estimated 47% of long COVID patients. Data from the Vaccine Adverse Event Reporting System (VAERS) shows that the most frequently reported symptoms after COVID-19 vaccination include headache, pyrexia (fever), and fatigue. From December 2020 through March 2023, VAERS received over 19,000 preliminary reports of death among vaccine recipients, with subsequent reviews by the CDC and FDA identifying nine deaths causally associated with the J&J/Janssen vaccine.
